Mercer Global Advisors Inc Jazz Pharmaceuticals PLC Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Mercer Global Advisors Inc holds 3,327 shares of JAZZ stock, worth $416,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,327

Previous 3,485 4.53%

Holding current value

$416,207

Previous $371,000 0.27%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.57 - $116.37 $15,890 - $18,386	-158 Reduced 4.53%	3,327 $370,000
Q2 2024 Aug 12, 2024	BUY	$103.94 - $118.98 $123,376 - $141,229	1,187 Added 51.65%	3,485 $371,000
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $42,044 - $48,461	-365 Reduced 13.71%	2,298 $277,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $12,797 - $15,232	-112 Reduced 4.04%	2,663 $328,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $9,638 - $11,479	79 Added 2.93%	2,775 $359,000
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $77,420 - $93,005	-632 Reduced 18.99%	2,696 $334,000
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $83,737 - $100,293	-625 Reduced 15.81%	3,328 $486,000
Q4 2022 Feb 08, 2023	SELL	$129.72 - $159.85 $14,398 - $17,743	-111 Reduced 2.73%	3,953 $630,000
Q3 2022 Nov 15, 2022	SELL	$126.59 - $161.18 $63,927 - $81,395	-505 Reduced 11.05%	4,064 $542,000
Q2 2022 Aug 10, 2022	SELL	$141.59 - $168.66 $36,388 - $43,345	-257 Reduced 5.33%	4,569 $713,000
Q1 2022 May 10, 2022	SELL	$129.64 - $160.7 $223,240 - $276,725	-1,722 Reduced 26.3%	4,826 $751,000
Q4 2021 Feb 04, 2022	SELL	$119.87 - $145.67 $71,802 - $87,256	-599 Reduced 8.38%	6,548 $834,000
Q3 2021 Nov 10, 2021	SELL	$128.64 - $184.79 $529,224 - $760,226	-4,114 Reduced 36.53%	7,147 $931,000
Q2 2021 Aug 10, 2021	SELL	$160.2 - $186.42 $82,503 - $96,006	-515 Reduced 4.37%	11,261 $2 Million
Q1 2021 Aug 10, 2021	BUY	$150.19 - $173.5 $2,252 - $2,602	15 Added 0.13%	11,776 $1.94 Million
Q1 2021 May 11, 2021	SELL	$150.19 - $173.5 $94,920 - $109,652	-632 Reduced 5.1%	11,761 $1.93 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $3.41 Million - $4 Million	-24,223 Reduced 66.15%	12,393 $2.05 Million
Q3 2020 Dec 10, 2020	SELL	$105.46 - $144.13 $17,189 - $23,493	-163 Reduced 0.44%	36,616 $5.22 Million
Q2 2020 Aug 10, 2020	BUY	$95.68 - $121.88 $839,974 - $1.07 Million	8,779 Added 31.35%	36,779 $4.06 Million
Q1 2020 May 18, 2020	BUY	$87.74 - $152.74 $2.19 Million - $3.81 Million	24,919 Added 808.8%	28,000 $2.79 Million
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $39,530 - $51,653	336 Added 12.24%	3,081 $460,000
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $10,264 - $11,745	-82 Reduced 2.9%	2,745 $351,000
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $32,391 - $37,275	258 Added 10.04%	2,827 $403,000
Q1 2019 Apr 23, 2019	SELL	$121.81 - $142.95 $238,991 - $280,467	-1,962 Reduced 43.3%	2,569 $367,000
Q1 2019 Apr 12, 2019	BUY	$121.81 - $142.95 $551,921 - $647,706	4,531 New	4,531 $562,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.84B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Jazz Pharmaceuticals PLC Transaction History